CastleVax

www.castlevax.com
175 Varick Street, Room 608
New York, NY 10014

Company Info

Year Established
2022

Contacts

Michael A. Egan, Ph.D.
CEO & CSO

Company Description

CastleVax is a clinical-stage vaccine research and development company devoted to the commercial development of the NDV vaccine platform technology with an initial focus on respiratory viruses.